The diagnosis and treatment of early psoriatic arthritis

Nature Reviews Rheumatology

Volumn 5, Issue 11, 2009, Pages 634-641

  Anandarajah, Allen P ^a   Ritchlin, Christopher T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

BONE SCINTISCANNING; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; ECHOGRAPHY; HUMAN; JOINT EFFUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSORIASIS AND ARTHRITIS QUESTIONNAIRE; PSORIATIC ARTHRITIS; QUESTIONNAIRE; REVIEW; SYNOVITIS; TENOSYNOVITIS;

ARTHRITIS, PSORIATIC; BIOLOGICAL FACTORS; DIAGNOSTIC IMAGING; HUMANS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350746171     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2009.210     Document Type: Review

References (61)

1. Gladman, D. D., Shuckett, R., Russell, M. L., Thorne, J. C. & Schachter, R. K. Psoriatic arthritis (PsA) - an analysis of 220 patients. Q. J. Med. 62, 127-141 (1987).
2. Kane, D., Stafford, L., Bresnihan, B. & FitzGerald, O. A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience. Rheumatology (Oxford) 42, 1460-1468 (2003).
3. Zachariae, H. et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations: Data from the Nordic Quality of Life Study. Acta Derm. Venereol. 82 108-113 (2002).
4. Harrison, B. J., Silman, A. J., Barrett, E. M., Scott, D. G. & Symmons, D. P. Presence of psoriasis does not influence the presentation of short-term outcome of patients with early inflammatory polyarthritis. J. Rheumatol. 24, 1744-1749 (1997).
5. Punzi, L. et al. Clinical, laboratory and immunogenetic aspects of post-traumatic psoriatic arthritis: A study of 25 patients. Clin. Exp. Rheumatol. 16, 277-281 (1998).
6. Harrison, B. J., Hutchinson, C. E., Adams, J., Bruce, I. N. & Herrick, A. L. Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann. Rheum. Dis. 61, 1007-1011 (2002).
7. Buskila, D., Langevitz, P., Gladman, D. D., Urowitz, S. & Smythe, H. A. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J. Rheumatol. 19, 1115-1119 (1992).
8. Queiro, R. et al. Clinically asymptomatic axial disease in psoriatic spondyloarthropathy. A retrospective study. Clin. Rheumatol. 21, 10-13 (2002).
9. Gelfand, J. M. et al. Epidemiology of psoriatic arthritis in the population of the United States. J. Am. Acad. Dermatol. 53, 573e1-e13 (2005).
10. Radtke, M., Reich, K., Blome, C., Rustenbach, S. & Augustin, M. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: Results of a German national survey. J. Eur. Acad. Dermatol. Venereol. 23, 683-691 (2009).
11. Reich, K., Krüger, K., Mössner, R. & Augustin, M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: A prospective interdisciplinary epidemiological study of 1,511 patients with plaque-type psoriasis. Br. J. Dermatol. 160, 1040-1047 (2009).
12. Qureshi, A. A. et al. Psoriatic arthritis screening tools. J. Rheumatol. 35, 1423-1425 (2008).
13. Peloso, P. M., Behl, M., Hull, P. & Reeder, B. The psoriasis and arthritis questionnaire (PAQ) in detection of arthritis among patients with psoriasis. Arthritis Rheum. 40 (Suppl.), S64 (1997).
14. Alenius, G. M., Stenberg, B., Stenlund, H., Lundblad, M. & Dahlqvist, S. R. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J. Rheumatol. 29, 2577-2582 (2002).
15. Husni, M. E., Meyer, K. H., Cohen, D. S., Mody, E. & Qureshi, A. A. The PASE questionnaire: Pilot testing a psoriatic arthritis screening and evaluation tool. J. Am. Acad. Dermatol. 57, 581-587 (2007).
16. Gladman, D. D. et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS). Ann. Rheum. Dis. 68, 497-501 (2009).
17. Ory, P. A., Gladman, D. & Mease, P. Psoriatic arthritis and imaging. Ann. Rheum. Dis. 64 (Suppl. 2), ii55-ii57 (2005).
18. Namey, T. C. & Rosenthall, L. Periarticular uptake of 99m technetium disphosphonate in psoriatics: Correlation with cutaneous activity. Arthritis Rheum. 19, 607-612 (1976).
19. Raza, N., Hameed, A. & Ali, M. K. Detection of subclinical joint involvement in psoriasis with bone scintigraphy and its response to methotrexate. Clin. Exp. Dermatol. 33, 70-73 (2008).
20. McQueen, F. M. et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosion at four months after symptom onset. Ann. Rheum. Dis. 57, 350-356 (1998).
21. Klarlund, M. et al. Magnetic resonance imaging, radiography and scintigraphy of the finger joints: One year follow up of patients with early arthritis. Ann. Rheum. Dis. 59, 521-528 (2000).
22. Offidani, A., Cellini, A., Valeri, G. & Giovagnoni, A. Subclinical joint involvements in psoriasis: Magnetic resonance imaging and X-ray findings. Acta Derm. Venereol. 78, 463-465 (1998).
23. Erdem, C. Z., Tekin, N. S., Sarikaya, S., Erdem, L. O. & Gulec, S. MR imaging features of foot involvement in patients with psoriasis. Eur. J. Radiol. 67, 521-525 (2008).
24. Wiell, C. et al. Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res. Ther. 9, R119 (2007).
25. Gisondi, P. et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: A hospital-based case-control study. Ann. Rheum. Dis. 67, 26-30 (2008).
26. De Filippis, L. G. et al. Ultrasonography in the early diagnosis of psoriasis-associated enthesopathy. Int. J. Tissue React. 27 159-162 (2005).
27. Ozcakar, L. et al. Ultrasonographical evaluation of the Achilles' tendon in psoriasis patients. Int. J. Dermatol. 44, 930-932 (2005).
28. De Simone, C. et al. Achilles tendonitis in psoriasis: Clinical spectrum and sonographic findings. J. Am. Acad. Dermatol. 49 217-222 (2003).
29. Galluzzo, E. et al. Sonographic analysis of the ankle in patients with psoriatic arthritis. Scand. J. Rheumatol. 29, 52-55 (2000).
30. McGonagle, D., Conaghan, P. G. & Emery, P. Psoriatic arthritis: A unified concept 20 years on. Arthritis Rheum. 42, 1080-1086 (1999).
31. Taylor, W. J., Fellow, D. E. & Helliwell, P. S. Case definition of psoriatic arthritis. Lancet 356, 2095 (2000).
32. Taylor, W. et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 54, 2665-2673 (2006).
33. Chandran, V. et al. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Care Res. 57, 1560-1563 (2009).
34. D'Angelo, S. et al. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J. Rheumatol. 36, 368-370 (2009).
35. Scarpa, R. et al. Early psoriatic arthritis: The clinical spectrum. J. Rheumatol. 35, 137-141 (2008).
36. Moll, J. M. & Wright, V. Psoriatic arthritis. Semin. Arthritis Rheum. 3, 55-78 (1973).
37. Marzo-Ortega, H. et al. Magnetic resonance imaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis. Scand. J. Rheumatol. 38, 79-83 (2009).
38. Jevtic, V. et al. Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol. 24, 351-355 (1995).
39. McGonagle, D. et al. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondyloarthropathy. Arthritis Rheum. 41, 694-700 (1998).
40. Jones, G., Crotty, M. & Brooks, P. Psoriatic arthritis: A quantitative overview of therapeutic options. The Psoriatic Arthritis Meta-Analysis Study Group. Br. J. Rheumatol. 36, 95-99 (1997).
41. Ritchlin, C. T. et al. Treatment recommendations for psoriatic arthritis. Ann. Rheum. Dis. 68, 1387-1394 (2009).
42. Soriani, E. R. & McHugh, N. Therapies for peripheral joint disease in psoriatic arthritis. A systemic review. J. Rheumatol. 33, 1422-1430 (2006).
43. Gelfand, J. M. et al. Risk of myocardial infarction in patients with psoriasis. JAMA 296, 1735-1741 (2006).
44. Abel, E. A., DiCicco, L. M., Orenberg, E. K., Fraki, J. E. & Farber, E. M. Drugs in exacerbation of psoriasis. J. Am. Acad. Dermatol. 15, 1007-1022 (1986).
45. Taylor, W. et al. Drug use and toxicity in psoriatic disease: focus on methotrexate. J. Rheumatol. 35, 1454-1457 (2008).
46. whiting-O'Keefe, Q. E., Fye, K. H. & Sack, K. D. Methotrexate and histologic hepatic abnormalities: A meta-analysis. Am. J. Med. 90, 711-716 (1991).
47. Linqvist, U. R. et al. The Swedish Early Psoriatic Arthritis Register - 2-year followup: A comparison with early rheumatoid arthritis. J. Rheumatol. 35, 668-673 (2008).
48. Anandarajah, A. P. & Ritchlin, C. T. Etanercept in psoriatic arthritis. Expert Opin. Biol. Ther. 3, 169-177 (2003).
49. Anandarajah, A. P. & Ritchlin, C. T. Infliximab in psoriatic arthritis. Fut. Rheumatol. 2, 13-22 (2007).
50. Mease, P. J. et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo controlled trial. Arthritis Rheum. 52, 3279-3289 (2005).
51. Kavanaugh, A. et al. Golimumab, a new human tumor necrosis factor alpha antibody administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum. 60, 976-986 (2009).
52. McQueen, F. M. et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum. 48, 1814-1827 (2003).
53. Anandarajah, A. P. et al. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow edema in patients with psoriatic arthritis. Ann. Rheum. Dis. 67, 296-301 (2008).
54. Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G. & Schwarz, E. M. Mechanisms of TNF alpha and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111 821-831 (2003).
55. Anandarajah, A. P. & Ritchlin, C. T. Pathogenesis of psoriatic arthritis. Curr. Opin. Rheumatol. 16, 338-343 (2004).
56. Partsch, G. et al. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis in synovial fluid. J. Rheumatol. 24, 518-523 (1997).
57. Ritchlin, C. et al. Patterns of cytokine production in psoriatic synovium. J. Rheumatol. 25, 1544-1552 (1998).
58. Rosenberg, P. et al. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment. J. Hepatol. 46, 1111-1118 (2007).
59. Nolan, B. v. & Feldman, S. R. Dermatologic medication adherence. Dermatol. Clin. 27, 113-120 (2009).
60. Bravo vergel, Y. et al. The cost effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford) 46, 1729-1735 (2007).
61. Goekoop-Ruiterman, Y. P. et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized controlled trial. Arthritis Rheum. 52, 3381-3390 (2005).